The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
 

Roland B. Walter

Corresponding Author: Roland B. Walter

Clinical Research Division

Fred Hutchinson Cancer Research Center

1100 Fairview Ave N

[email]@fhcrc.org

Name/email consistency: high

 
 
 
 
 
 
 

Affiliations

  • Corresponding Author: Roland B. Walter, Clinical Research Division, Fred Hutchinson Cancer Research Center, 1100 Fairview Ave N. 2002 - 2011
  • Medical Clinic B and Division of Oncology, Department of Internal Medicine, University Hospital, Zürich, Switzerland. 2002

References

  1. Cancer Risk Associated with Long-term Use of Acetaminophen in the Prospective VITamins and Lifestyle (VITAL) Study. Walter, R.B., Brasky, T.M., White, E. Cancer Epidemiol. Biomarkers Prev. (2011) [Pubmed]
  2. Prediction of early death after induction therapy for newly diagnosed acute myeloid leukemia with pretreatment risk scores: a novel paradigm for treatment assignment. Walter, R.B., Othus, M., Borthakur, G., Ravandi, F., Cortes, J.E., Pierce, S.A., Appelbaum, F.R., Kantarjian, H.A., Estey, E.H. J. Clin. Oncol. (2011) [Pubmed]
  3. Long-Term Use of Acetaminophen, Aspirin, and Other Nonsteroidal Anti-Inflammatory Drugs and Risk of Hematologic Malignancies: Results From the Prospective Vitamins and Lifestyle (VITAL) Study. Walter, R.B., Milano, F., Brasky, T.M., White, E. J. Clin. Oncol. (2011) [Pubmed]
  4. Impact of pretransplantation minimal residual disease, as detected by multiparametric flow cytometry, on outcome of myeloablative hematopoietic cell transplantation for acute myeloid leukemia. Walter, R.B., Gooley, T.A., Wood, B.L., Milano, F., Fang, M., Sorror, M.L., Estey, E.H., Salter, A.I., Lansverk, E., Chien, J.W., Gopal, A.K., Appelbaum, F.R., Pagel, J.M. J. Clin. Oncol. (2011) [Pubmed]
  5. Effect of complete remission and responses less than complete remission on survival in acute myeloid leukemia: a combined Eastern Cooperative Oncology Group, Southwest Oncology Group, and M. D. Anderson Cancer Center Study. Walter, R.B., Kantarjian, H.M., Huang, X., Pierce, S.A., Sun, Z., Gundacker, H.M., Ravandi, F., Faderl, S.H., Tallman, M.S., Appelbaum, F.R., Estey, E.H. J. Clin. Oncol. (2010) [Pubmed]
  6. High expression of the very late antigen-4 integrin independently predicts reduced risk of relapse and improved outcome in pediatric acute myeloid leukemia: a report from the children's oncology group. Walter, R.B., Alonzo, T.A., Gerbing, R.B., Ho, P.A., Smith, F.O., Raimondi, S.C., Hirsch, B.A., Gamis, A.S., Franklin, J.L., Hurwitz, C.A., Loken, M.R., Meshinchi, S. J. Clin. Oncol. (2010) [Pubmed]
  7. Simultaneously targeting CD45 significantly increases cytotoxicity of the anti-CD33 immunoconjugate, gemtuzumab ozogamicin, against acute myeloid leukemia (AML) cells and improves survival of mice bearing human AML xenografts. Walter, R.B., Boyle, K.M., Appelbaum, F.R., Bernstein, I.D., Pagel, J.M. Blood (2008) [Pubmed]
  8. ITIM-dependent endocytosis of CD33-related Siglecs: role of intracellular domain, tyrosine phosphorylation, and the tyrosine phosphatases, Shp1 and Shp2. Walter, R.B., Raden, B.W., Zeng, R., Häusermann, P., Bernstein, I.D., Cooper, J.A. J. Leukoc. Biol. (2008) [Pubmed]
  9. Phosphorylated ITIMs enable ubiquitylation of an inhibitory cell surface receptor. Walter, R.B., Häusermann, P., Raden, B.W., Teckchandani, A.M., Kamikura, D.M., Bernstein, I.D., Cooper, J.A. Traffic (2008) [Pubmed]
  10. CD33 expression and P-glycoprotein-mediated drug efflux inversely correlate and predict clinical outcome in patients with acute myeloid leukemia treated with gemtuzumab ozogamicin monotherapy. Walter, R.B., Gooley, T.A., van der Velden, V.H., Loken, M.R., van Dongen, J.J., Flowers, D.A., Bernstein, I.D., Appelbaum, F.R. Blood (2007) [Pubmed]
  11. Influence of CD33 expression levels and ITIM-dependent internalization on gemtuzumab ozogamicin-induced cytotoxicity. Walter, R.B., Raden, B.W., Kamikura, D.M., Cooper, J.A., Bernstein, I.D. Blood (2005) [Pubmed]
  12. PK11195, a peripheral benzodiazepine receptor (pBR) ligand, broadly blocks drug efflux to chemosensitize leukemia and myeloma cells by a pBR-independent, direct transporter-modulating mechanism. Walter, R.B., Pirga, J.L., Cronk, M.R., Mayer, S., Appelbaum, F.R., Banker, D.E. Blood (2005) [Pubmed]
  13. Multidrug resistance protein attenuates gemtuzumab ozogamicin-induced cytotoxicity in acute myeloid leukemia cells. Walter, R.B., Raden, B.W., Hong, T.C., Flowers, D.A., Bernstein, I.D., Linenberger, M.L. Blood (2003) [Pubmed]
  14. Gemcitabine-associated hemolytic-uremic syndrome. Walter, R.B., Joerger, M., Pestalozzi, B.C. Am. J. Kidney Dis. (2002) [Pubmed]
  15. Life-threatening thrombocytopenia associated with acute Epstein-Barr virus infection in an older adult. Walter, R.B., Hong, T.C., Bachli, E.B. Ann. Hematol. (2002) [Pubmed]
 
WikiGenes - Universities